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matrix deposition. Vascular remodeling appears to be caused by
complicated processes, in which the renin-angiotensin-aldosterone
system is involved. In this sense, we fully agree with Drs. Davidson
and Struthers that CNP should be regarded as an endogenous
regulator of the vascular renin-angiotensin-aldosterone system (2).
In our porcine model of inflammatory coronary arteriosclerosis,
which is characterized by constrictive remodeling and neointimal
formation, a complex cytokine network appears to be involved,
including several growth factors and inflammatory cytokines (3).
Furthermore, recent studies suggested that other mechanisms,
such as endothelial dysfunction, collagen accumulation, and
matrix-metalloproteinase activity, may also be involved in the
pathogenesis of vascular remodeling (4,5). We have recently
demonstrated that small GTP binding protein Rho and its target
Rho-kinase play an important role in the molecular mechanism of
vascular hyperreactivity as well as vascular remodeling in our
porcine model (6,7). Importantly, the Rho/Rho-kinase pathway is
involved in the cardiovascular effects of angiotensin II (8).
Taken together, it is highly possible in our study that the
inhibitory effect of CNP on the development of vascular remod-
eling was mediated, at least in part, by its modulatory effect on the
vascular renin-angiotensin-aldoesterone system. However, it re-
mains to be examined whether adenovirus-mediated overexpres-
sion of CNP in the coronary artery actually reduces the local
production of angiotensin II in our porcine model in vivo.
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Stress Testing and Electron
Beam Computed Tomography
for Evaluation of Patients With
Suspected Coronary Artery Disease
I read with interest the study by Shavelle et al. (1) on the value of
exercise testing and electron beam computed tomography (EBCT)
in the evaluation of coronary artery disease (CAD). The investi-
gators report that when applied to a population referred for
angiography, EBCT has a sensitivity of 96% and a specificity of
47% for detection of significant CAD (defined as $50% diameter
stenosis), and they conclude that “Electron beam computed to-
mography has a higher diagnostic ability than either treadmill
ECG or technetium-stress for the detection of obstructive angio-
graphic CAD.” They also suggest that a combination of EBCT
(for optimal sensitivity) with ECG stress testing (for improved
specificity and functional information) might be the preferred
approach for evaluating patients with suspected CAD.
Both these conclusions have to be viewed with skepticism: The
sensitivity of nuclear stress testing in their study (78%) is low,
almost equal to that of treadmill ECG (76%). When a broader
definition of “positive scan results” was used (either fixed or
reversible perfusion defects), the sensitivity was even lower (75%).
Other than a typographic error, I can see no explanation to this
paradox. Several studies have demonstrated that nuclear stress
testing has a significantly higher sensitivity for detection of CAD
than hereby presented. Even in the meta-analysis that the inves-
tigators quote (2), an almost 10% higher sensitivity (87%) was
reported, despite the inclusion of several older studies and some
with a stricter definition of “significant CAD” ($70% diameter
stenosis).
The investigators identify a number of reasons that could
explain the lower than expected specificity of nuclear testing in
their study, including the absence of ECG-gating and the high
likelihood of attenuation-induced defects. However, the low sen-
sitivity in the study is not adequately explained: If both fixed and
reversible defects were considered as abnormal, the underestima-
tion of reversibility that the authors quote (3,4) (and which has
been described for assessment of myocardial viability) should not
underestimate the sensitivity for detection of CAD. Moreover, the
potential Tc-99m redistribution that the researchers consider as a
source of decreased test sensitivity is minimal (3,5), if any at all
(6,7), and is unlikely to completely normalize significant perfusion
defects. In any case, the reference that Shavelle et al. quote (8) to
support their contention that redistribution might account for their
low Tc-99m stress test sensitivity does not address this issue.
Finally, the combined assessment of EBCT and treadmill ECG
should be evaluated with caution. In the Shavelle et al. study, 27
patients with a positive EBCT scan, one third of all positive
EBCT scans, were considered as having a negative “test.” What
was the severity of coronary calcification in these patients? Should
not the extent of calcification also be taken into account, if a
combined test approach were to be used?
The utility of EBCT as a research tool is unquestionable.
However, the clinical utility of EBCT, and for that matter any
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diagnostic test, should be judged on its incremental value above and
beyond existing tests, or by the demonstration of a lower cost with
at least equal diagnostic and prognostic value. The fact that EBCT
has relatively low cost does not necessarily mean that it is also a
cost-efficient technique. The study by Shavelle et al. (1) does not
include a cost-efficiency analysis, and until newer data are available,
the clinical role of EBCT (or EBCT plus treadmill ECG) for
evaluation of patients with suspected CAD remains uncertain.
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Evaluating Coronary Artery Disease—
Where Does EBCT Fit In?
We congratulate Shavelle et al. (1) on their study in which they
present data comparing the use of electron beam computed
tomography (EBCT), treadmill-electrocardiogram (ECG) and
technetium-stress testing to identify patients with coronary artery
disease (CAD). The investigators conclude that EBCT has a
higher diagnostic ability than either treadmill-ECG or
technetium-stress for the detection of CAD. There are several
important issues, however, that should be addressed when inter-
preting the results of their study.
First, it is important to note that the authors chose to study a
high-risk population in which 69% of patients had CAD. In most
populations undergoing screening tests, the disease prevalence is
much lower. Some diagnostic test characteristics are affected by
disease prevalence, including positive and negative predictive
values and accuracy. Consequently, studies of diagnostic tests often
present predictive values and accuracy that are calculated for
lower-risk populations, as well as likelihood ratios that are inde-
pendent of disease prevalence. Using data from the report by
Shavelle et al., we calculated predictive values and accuracy using a
lower disease prevalence than the one reported in their paper
(Table 1). Moreover, we calculated likelihood ratios for the three
diagnostic tests. Positive predictive values for the three tests were
similarly poor, suggesting that each of these tests has a poor
diagnostic value for CAD in low-risk populations. At the same
time, EBCT had the highest negative predictive value (98%),
suggesting that the strength of EBCT lies in its ability to rule out
CAD. When we calculated the accuracy of each of the three tests,
using a more typical disease prevalence, EBCT was the least
accurate. However, EBCT had the best negative likelihood ratio,
reaffirming its strength in ruling out CAD. When we calculated
positive likelihood ratios, technetium-stress testing was somewhat
better at identifying patients with CAD. Thus, EBCT may not be
the ideal test to identify patients with CAD in a general population.
A second issue is that the investigators’ study may be limited by
the sensitivity and specificity they found for technetium-stress
testing. The numbers that they report are lower than those found
in previous studies. Because the investigators examined only 97
patients, they may have inadvertently underestimated the sensitiv-
Table 1. Diagnostic Test Characteristics of Treadmill-ECG, Technetium-Stress, Exercise Echocardiography and EBCT for Patients
With a High and Low Risk of CAD
Sensitivity
(%)
Specificity
(%)
Accuracy
(%)
Positive
Predictive
Value (%)
Negative
Predictive
Value (%)
Positive
Likelihood
Ratio
Negative
Likelihood
Ratio
Study Population (disease prevalence 5 69%)
Treadmill-ECG 76 60 71 81 53 1.9 0.4
Technetium-stress 78 67 74 83 57 2.4 0.3
EBCT 96 47 80 80 82 1.8 0.1
Typical Population (disease prevalence 5 20%)
Treadmill-ECG 76 60 63 32 91 1.9 0.4
Technetium-stress 78 67 69 37 92 2.4 0.3
EBCT 96 47 57 31 98 1.8 0.1
Typical Population (disease prevalence 5 20%)
Technetium-stress* 87 64 69 38 95 2.4 0.2
Exercise-echocardiography* 85 77 79 48 95 3.7 0.2
*Assuming sensitivity and specificity from meta-analysis (2).
CAD 5 coronary artery disease; EBCT 5 electron beam computed tomography; ECG 5 electrocardiogram.
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